CI earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 12.01. Updated 2026-07-23.
Cigna (CI) Research Hub
Cigna (CI) trades on NYSE, US in the Healthcare (Medical - Healthcare Plans) sector. As of 2026-09-11, shares last closed at 280.76 USD (+0.93%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 12.01, market cap 76.39B. This hub links to the full technical, earnings and options research available for CI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Plans) |
|---|---|
| Exchange | NYSE, US |
| Last close | 280.76 USD (+0.93%) |
| 52-week range | 269.01 USD – 305.25 USD |
| Trend regime | Range |
| 14-day RSI | 48.1 (Neutral) |
| Trailing P/E | 12.01 |
| Market cap | 76.39B |
| Dividend yield | 2.16% |
| Next earnings | 2026-07-30 |
Available research for CI
Covered Call on CI: how it works, illustrative setup around the real 280.76 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CI: how it works, illustrative setup around the real 280.76 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CI: how it works, illustrative setup around the real 280.76 USD price, max profit/loss, breakeven and when to use it. Educational.
CI technical analysis: range, last 280.76 USD, RSI 48.1, 52w range 269.01 USD–305.25 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CI in?
Cigna (CI) is classified under Healthcare (Medical - Healthcare Plans), listed on NYSE, US.
Is CI in an uptrend or downtrend?
As of 2026-09-11, CI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CI's trailing P/E ratio?
CI's trailing P/E is 12.01, with a market cap of 76.39B. See the earnings research page for full valuation detail.
When does CI next report earnings?
CI is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 7.6 USD.